Metlife Inc [MET] stock is trading at $82.61, up 0.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MET shares have gain 5.80% over the last week, with a monthly amount glided 3.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Metlife Inc [NYSE: MET] stock has seen the most recent analyst activity on September 19, 2025, when Piper Sandler downgraded its rating to a Neutral but kept the price target unchanged to $84 for it. Previously, Wolfe Research started tracking the stock with Outperform rating on September 16, 2025, and set its price target to $95. On January 23, 2025, BMO Capital Markets initiated with a Market Perform rating and assigned a price target of $97 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $97 on October 09, 2024. Barclays initiated its recommendation with an Overweight and recommended $91 as its price target on September 05, 2024. Goldman upgraded its rating to Buy for this stock on January 08, 2024, but kept the price target unchanged to $80.
Metlife Inc [MET] stock has fluctuated between $65.21 and $88.09 over the past year. Currently, Wall Street analysts expect the stock to reach $95.8 within the next 12 months. Metlife Inc [NYSE: MET] shares were valued at $82.61 at the most recent close of the market. An investor can expect a potential return of 15.97% based on the average MET price forecast.
Analyzing the MET fundamentals
Metlife Inc [NYSE:MET] reported sales of 71.94B for the trailing twelve months, which represents a drop of -5.85%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.14 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 82.06 points at the first support level, and at 81.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 83.30, and for the 2nd resistance point, it is at 83.98.
Ratios To Look Out For
For context, Metlife Inc’s Current Ratio is 4.79. Considering the valuation of this stock, the price to sales ratio is 0.76, the price to book ratio is 1.89 and price to earnings (TTM) ratio is 15.55.
Transactions by insiders
Recent insider trading involved MetLife Separate Account SPI, Affiliate, that happened on Dec 01 ’25 when 335.0 shares were purchased. Affiliate, Separate Account 149- Metropol completed a deal on Nov 20 ’25 to buy 30.0 shares. Meanwhile, Affiliate discretionary manage Russell 1000 Value MetLife 401 bought 196.0 shares on Oct 29 ’25.
